With the introduction of Emepelle to the Australian market, clinicians now have access to the first and only skincare range specifically formulated to address the unique skin challenges of perimenopause and menopause. Utilising non-hormonal MEP Technology, this scientifically advanced cosmeceutical range is opening the door to an entirely new category of skincare.
According to Dr David Kosenko, President of the Cosmetic Physicians College of Australasia (CPCA) and Medical Director of Dermocosmètica, the distributor of Emepelle in Australia, this development marks a pivotal shift in how skin ageing in menopausal women is treated.
‘The inclusion of Methyl-estradiol propionate (MEP) makes the Emepelle range a new and unique category of skincare,’ he says. ‘It specifically targets the changes that occur in the skin during and after menopause. Traditional skincare products do not address the changes that result from oestrogen deficiency.’
A deeper look at hormonal skin ageing
While wrinkles, dryness and laxity are familiar signs of skin ageing, the hormonal shifts that accelerate these changes during menopause are often less understood. Oestrogen plays a critical role in maintaining skin health. As hormone levels begin to decline in perimenopause, often starting in the early 40s, women begin to notice changes in their skin texture, sensitivity and overall tone.
Dr Simone Bamford, Medical Director of Bayside Medical Aesthetics, sees this firsthand in her clinic. ‘Starting in perimenopause, women experience skin changes due to the reduction of oestrogen in the body,’ she says.
‘The first sign is often dullness and increased sensitivity – suddenly they’re not able to tolerate products they’ve used for years. That’s due to the outer layer of the skin becoming less effective as a barrier, along with reduced production of sebum, ceramides and hyaluronic acid. It often leads to dryness, irritation and sometimes even itching.’
These surface-level changes are accompanied by deeper, structural transformations. Collagen loss becomes more pronounced, with research estimating up to 30 percent of the skin’s collagen is lost within the first five years after menopause. This leads to thinner, less elastic skin, along with more noticeable fine lines, deeper wrinkles and facial sagging. Women also report increased vascularity, pigmentation in sun-exposed areas and slower wound healing.
‘Facial skin has a high concentration of oestrogen receptors,’ says Dr Kosenko. ‘By using Emepelle with MEP Technology, these receptors can be stimulated without the use of systemic hormones. The result is increased hydration, elasticity and skin thickness, as well as a reduction in the appearance of lines and wrinkles.’
MEP Technology: a targeted, non-hormonal approach
MEP (Methyl-estradiol propionate) is the proprietary molecule at the heart of the Emepelle range. Unlike hormone replacement therapy (HRT), MEP is non-hormonal. It binds to oestrogen receptors in the skin to restore function and structure, without affecting systemic hormone levels. This makes it an attractive, localised option for patients seeking skin rejuvenation without the risks associated with hormonal treatments.
Emepelle’s product line consists of three key products that are designed to be used in tandem. The Day Serum combines MEP with antioxidants such as niacinamide, vitamin C, vitamin E, ferulic acid and peptides, offering comprehensive support for daytime use. The Night Cream features MEP along with niacinamide, retinol, peptides and Matrixyl 3000 to deeply hydrate and enhance skin texture while helping to reduce visible signs of ageing during overnight repair. Rounding out the range is the Eye Cream, which includes MEP, vitamin E, caffeine and peptides to address puffiness, dark circles and fine lines around the delicate eye area.
In practice, Dr Bamford has found that simplifying skincare routines during the menopausal transition is key.
‘Generally, if women are noticing increased sensitivity, they should pare back their routine – pause on the strong actives like vitamin C or AHAs, and focus on repairing the barrier first with gentle, non-foaming cleansers and ingredients like hyaluronic acid and niacinamide,’ she advises.
‘Once the skin is more stable, Emepelle can be introduced. It’s very well tolerated, even in sensitive skin, and my patients often say they notice their skin feeling plumper, more hydrated and with that healthy glow returning.’
Patients are also appreciating the simplicity of the regimen – just one product for the morning and one for the evening. ‘They’re keen to continue long-term because it’s effective and easy,’ Dr Bamford adds. ‘It’s not just about anti-ageing; it’s about restoring confidence in their skin.’
As conversations around menopause become more open, the demand for tailored solutions continues to grow. For many women, these are decades-long concerns.
‘Women are wanting their skin to look its best not just for the next 10 years, but potentially the next 40 or 50,’ says Dr Bamford. ‘Emepelle addresses that need in a targeted, scientifically supported way.’
Dr Kosenko echoes the importance of recognising skin health as a key aspect of women’s health: ‘The skin is the body’s largest organ and it’s highly responsive to hormonal change. Supporting menopausal skin is not a luxury – it’s an important part of overall health and wellbeing.’
With Emepelle, Australian practitioners now have an effective, science-led option for managing skin changes during menopause without the need for systemic hormones. It’s a long-overdue innovation that’s helping redefine how we care for skin through one of life’s most significant transitions.
To learn more about Emepelle or enquire about stockist opportunities, contact Dermocosmètica.
